Primerica Reports Third Quarter 2022 Results
Primerica reported its Q3 2022 results, indicating a 3% growth in its life-licensed sales force, with term life net premiums increasing 6%. However, total revenues fell 3% to $673.3 million, driven by a 23% drop in Investment and Savings Products sales to $2.2 billion. The net income decreased 54% to $51.8 million, impacted by a $60 million goodwill impairment. Adjusted EPS increased 1% to $3.02. Primerica declared a $0.55 dividend and repurchased $97 million in stock. Despite market volatility, net client inflows in Investment and Savings Products remained positive at $0.7 billion.
- Life-licensed sales force grew by 3%, totaling 134,313 representatives.
- Term Life net premiums increased 6%, totaling $427.8 million.
- Adjusted operating EPS rose 1% to $3.02.
- Total revenues dropped 3% to $673.3 million.
- Net income decreased by 54% to $51.8 million.
- Investment and Savings Products sales fell 23%, reflecting challenging market conditions.
Life-licensed sales force grew
Term Life net premiums increased
Investment and Savings Products sales of
Net earnings per diluted share (EPS) of
Diluted adjusted operating EPS of
Declared dividend of
The Company excludes the goodwill impairment charge from adjusted operating results as it represents a non-recurring item that causes incomparability of the Company’s core results between periods. Adjusted operating revenues were
Operating results during the quarter were pressured by market volatility, which led to a substantial decline in client asset values and lower sales volume in the Investment and Savings Product segment. Continued growth in Term Life earnings partly offset the negative impact of equity markets on the current period’s financial results. The Company continues to make progress in addressing challenges in the senior health distribution marketplace. Insurance and other operating expense growth has normalized as expected from the higher growth levels reported earlier in the year. The Company continues to make significant progress in growing the size of the independent life-licensed sales force by leveraging improvements in the licensing process and the excitement generated at the biennial convention.
“Our focus remains on serving the protection and savings needs of our clients during these times of market volatility and economic uncertainty as we expand the size of our sales force,” said
Third Quarter Distribution & Segment Results
Distribution Results |
|||||||||||||
|
|
Q3 2022 |
|
|
Q3 2021 |
|
|
% Change |
|
|
|||
Life-Licensed Sales Force (1) |
|
|
134,313 |
|
|
|
130,023 |
|
|
|
3 |
% |
|
Recruits |
|
|
127,788 |
|
|
|
91,884 |
|
|
|
39 |
% |
|
New Life-Licensed Representatives |
|
|
12,518 |
|
|
|
9,381 |
|
|
|
33 |
% |
|
Life Insurance Policies Issued |
|
|
71,104 |
|
|
|
75,914 |
|
|
|
(6 |
)% |
|
Life Productivity (2) |
|
|
0.18 |
|
|
|
0.19 |
|
|
* |
|
|
|
ISP Product Sales ($ billions) |
|
$ |
2.16 |
|
|
$ |
2.79 |
|
|
|
(23 |
)% |
|
Average Client Asset Values ($ billions) |
|
$ |
83.32 |
|
|
$ |
92.65 |
|
|
|
(10 |
)% |
|
Senior Health Submitted Policies (3) |
|
|
16,095 |
|
|
|
20,867 |
|
|
|
(23 |
)% |
|
Senior Health Approved Policies (4) |
|
|
14,862 |
|
|
|
18,276 |
|
|
|
(19 |
)% |
|
Closed |
|
$ |
99.8 |
|
|
$ |
337.6 |
|
|
|
(70 |
)% |
|
___________________ |
|
(1) |
End of period. The 2021 period includes an estimated 800 individuals who we expected would not pursue the steps necessary to convert a COVID-related temporary license to a permanent license or renew a license with a COVID-related extended renewal date. |
(2) |
Life productivity equals policies issued divided by the average number of life insurance licensed representatives per month. |
(3) |
Represents the number of completed applications that, with respect to each such application, the applicant has authorized us to submit to the health insurance carrier. |
(4) |
Represents an estimate of submitted policies approved by health insurance carriers during the indicated period. Not all approved policies will go in force. |
* Not calculated |
Segment Results |
|||||||||||||
|
|
Q3 2022 |
|
|
Q3 2021 |
|
|
% Change |
|
|
|||
|
|
($ in thousands) |
|||||||||||
Adjusted Operating Revenues: |
|
|
|
|
|
|
|
|
|
|
|||
|
|
$ |
427,830 |
|
|
$ |
401,451 |
|
|
|
7 |
% |
|
Investment and Savings Products |
|
|
201,697 |
|
|
|
233,337 |
|
|
|
(14 |
)% |
|
|
|
|
17,184 |
|
|
|
22,936 |
|
|
|
(25 |
)% |
|
Corporate and Other Distributed Products (1) |
|
|
29,345 |
|
|
|
34,745 |
|
|
|
(16 |
)% |
|
Total adjusted operating revenues (1) |
|
$ |
676,056 |
|
|
$ |
692,469 |
|
|
|
(2 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|||
Adjusted Operating Income (Loss) before income taxes: |
|
|
|
|
|
|
|
|
|
|
|||
|
|
$ |
111,764 |
|
|
$ |
107,589 |
|
|
|
4 |
% |
|
Investment and Savings Products |
|
|
58,377 |
|
|
|
69,368 |
|
|
|
(16 |
)% |
|
|
|
|
(3,723 |
) |
|
|
(6,608 |
) |
|
|
(44 |
)% |
|
Corporate and Other Distributed Products (1) |
|
|
(17,752 |
) |
|
|
(13,529 |
) |
|
|
31 |
% |
|
Total adjusted operating income before income taxes (1) |
|
$ |
148,666 |
|
|
$ |
156,820 |
|
|
|
(5 |
)% |
|
___________________ |
|
(1) |
See the Non-GAAP Financial Measures section and the Adjusted Operating Results reconciliation tables at the end of this release for additional information. |
Life Insurance Licensed Sales Force
Licensing momentum continued with 12,518 new life-licensed representatives being added during the third quarter of 2022, a
During the third quarter of 2022, the Company issued 71,104 new life insurance policies, a decrease of
Third quarter revenues of
Investment and Savings Products
Total product sales during the quarter were
Revenues of
The third quarter results reflected seasonally lower activity levels ahead of the Annual Enrollment Period, which started on
The pre-tax operating loss during the third quarter was
Corporate and Other Distributed Products
During the third quarter, the segment recorded an adjusted operating loss before taxes of
Invested Asset Portfolio
Consolidated net investment income increased
The invested asset portfolio ended the quarter with an unrealized loss of
Taxes
The effective tax rate was
Capital
During the third quarter, the Company repurchased
Primerica has a strong balance sheet, including invested assets and cash at the holding company of
Non-GAAP Financial Measures
In addition to reporting financial results in accordance with
Our definitions of these non-GAAP financial measures may differ from the definitions of similar measures used by other companies. Management uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating the Company’s performance. Furthermore, management believes that these non-GAAP financial measures may provide users with additional meaningful comparisons between current results and results of prior periods as they are expected to be reflective of the core ongoing business. These measures have limitations and investors should not consider them in isolation or as a substitute for analysis of the Company’s results as reported under GAAP. Reconciliations of GAAP to non-GAAP financial measures are attached to this release.
Earnings Webcast Information
Primerica will hold a webcast on
Forward-Looking Statements
Except for historical information contained in this press release, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements contain known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from anticipated or projected results. Those risks and uncertainties include, among others, our failure to continue to attract and license new recruits, retain sales representatives or license or maintain the licensing of sales representatives; new laws or regulations that could apply to our distribution model, which could require us to modify our distribution structure; changes to the independent contractor status of sales representatives; our or sales representatives’ violation of or non-compliance with laws and regulations; any failure to protect the confidentiality of client information; differences between our actual experience and our expectations regarding mortality or persistency as reflected in the pricing for our insurance policies; changes in federal, state and provincial legislation or regulation that affects our insurance, investment product and mortgage businesses; our failure to meet regulatory capital ratios or other minimum capital and surplus requirements; a significant downgrade by a ratings organization; the failure of our reinsurers or reserve financing counterparties to perform their obligations; the failure of our investment products to remain competitive with other investment options or the loss of our relationship with one or more of the companies whose investment products we provide; litigation and regulatory investigations and actions concerning us or sales representatives; heightened standards of conduct or more stringent licensing requirements for sales representatives; inadequate policies and procedures regarding suitability review of client transactions; revocation of our subsidiary’s status as a non-bank custodian; economic down cycles that impact our business, financial condition and results of operations; major public health pandemics, epidemics or outbreaks or other catastrophic events; the failure of our information technology systems, breach of our information security, failure of our business continuity plan or the loss of the Internet; the effects of credit deterioration and interest rate fluctuations on our invested asset portfolio and other assets; incorrectly valuing our investments; changes in accounting standards may impact how we record and report our financial condition and results of operations; the inability of our subsidiaries to pay dividends or make distributions; litigation and regulatory investigations and actions; a significant change in the competitive environment in which we operate; the loss of key personnel or sales force leaders; any acquisition or investment in businesses that do not perform as we expect or are difficult to integrate; due to our very limited history with e-TeleQuote, we cannot be certain that its business will be successful or that we will successfully address any risks not known to us that may become material; a failure by e-TeleQuote to comply with the requirements of
About
|
|
|||||||
Condensed Consolidated Balance Sheets |
|
|||||||
|
|
|||||||
|
|
(Unaudited) |
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
(In thousands) |
|
|||||
Assets |
|
|
|
|
|
|
||
Investments: |
|
|
|
|
|
|
||
Fixed-maturity securities available-for-sale, at fair value |
|
$ |
2,457,989 |
|
|
$ |
2,702,567 |
|
Fixed-maturity security held-to-maturity, at amortized cost |
|
|
1,433,760 |
|
|
|
1,379,100 |
|
Short-term investments available-for-sale, at fair value |
|
|
- |
|
|
|
85,243 |
|
Equity securities, at fair value |
|
|
33,079 |
|
|
|
42,551 |
|
Trading securities, at fair value |
|
|
3,718 |
|
|
|
24,355 |
|
Policy loans and other invested assets |
|
|
48,787 |
|
|
|
30,612 |
|
Total investments |
|
|
3,977,333 |
|
|
|
4,264,428 |
|
Cash and cash equivalents |
|
|
438,025 |
|
|
|
392,501 |
|
Accrued investment income |
|
|
19,949 |
|
|
|
18,702 |
|
Reinsurance recoverables |
|
|
4,033,897 |
|
|
|
4,268,419 |
|
Deferred policy acquisition costs, net |
|
|
3,049,102 |
|
|
|
2,943,782 |
|
Renewal commissions receivable |
|
|
198,027 |
|
|
|
231,751 |
|
Agent balances, due premiums and other receivables |
|
|
266,831 |
|
|
|
257,675 |
|
|
|
|
127,707 |
|
|
|
179,154 |
|
Intangible assets |
|
|
188,150 |
|
|
|
195,825 |
|
Income taxes |
|
|
90,719 |
|
|
|
81,799 |
|
Operating lease right-of-use assets |
|
|
42,343 |
|
|
|
47,942 |
|
Other assets |
|
|
403,452 |
|
|
|
441,253 |
|
Separate account assets |
|
|
2,206,608 |
|
|
|
2,799,992 |
|
Total assets |
|
$ |
15,042,143 |
|
|
$ |
16,123,223 |
|
|
|
|
|
|
|
|
||
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
||
Liabilities: |
|
|
|
|
|
|
||
Future policy benefits |
|
$ |
7,314,688 |
|
|
$ |
7,138,649 |
|
Unearned and advance premiums |
|
|
16,153 |
|
|
|
16,437 |
|
Policy claims and other benefits payable |
|
|
496,563 |
|
|
|
585,382 |
|
Other policyholders' funds |
|
|
492,479 |
|
|
|
501,823 |
|
Notes payable - short term |
|
|
- |
|
|
|
15,000 |
|
Notes payable - long term |
|
|
592,705 |
|
|
|
592,102 |
|
Surplus note |
|
|
1,433,293 |
|
|
|
1,378,585 |
|
Income taxes |
|
|
129,347 |
|
|
|
241,311 |
|
Operating lease liabilities |
|
|
47,935 |
|
|
|
53,920 |
|
Other liabilities |
|
|
611,646 |
|
|
|
615,710 |
|
Payable under securities lending |
|
|
80,754 |
|
|
|
94,529 |
|
Separate account liabilities |
|
|
2,206,608 |
|
|
|
2,799,992 |
|
Total liabilities |
|
|
13,422,171 |
|
|
|
14,033,440 |
|
|
|
|
|
|
|
|
||
Temporary Stockholders' Equity |
|
|
|
|
|
|
||
Redeemable noncontrolling interests in consolidated entities |
|
|
- |
|
|
|
7,271 |
|
|
|
|
|
|
|
|
||
Permanent Stockholders' equity |
|
|
|
|
|
|
||
Equity attributable to |
|
|
|
|
|
|
||
Common stock |
|
|
370 |
|
|
|
394 |
|
Paid-in capital |
|
|
- |
|
|
|
5,224 |
|
Retained earnings |
|
|
1,887,952 |
|
|
|
2,004,506 |
|
Accumulated other comprehensive income (loss), net of income tax |
|
|
(268,350 |
) |
|
|
72,388 |
|
Total permanent stockholders' equity |
|
|
1,619,972 |
|
|
|
2,082,512 |
|
Total liabilities and temporary and permanent stockholders' equity |
|
$ |
15,042,143 |
|
|
$ |
16,123,223 |
|
|
|
|||||||
Condensed Consolidated Statements of Income |
|
|||||||
(Unaudited) |
|
|||||||
|
|
|
|
|
|
|
||
|
|
Three months ended |
|
|||||
|
|
2022 |
|
|
2021 |
|
||
|
|
(In thousands, except per-share amounts) |
|
|||||
Revenues: |
|
|
|
|
|
|
||
Direct premiums |
|
$ |
810,079 |
|
|
$ |
785,277 |
|
Ceded premiums |
|
|
(404,870 |
) |
|
|
(401,295 |
) |
Net premiums |
|
|
405,209 |
|
|
|
383,982 |
|
Commissions and fees |
|
|
225,468 |
|
|
|
269,796 |
|
Net investment income |
|
|
24,346 |
|
|
|
20,000 |
|
Investment gains (losses) |
|
|
(2,699 |
) |
|
|
1,410 |
|
Other, net |
|
|
20,965 |
|
|
|
18,051 |
|
Total revenues |
|
|
673,289 |
|
|
|
693,239 |
|
|
|
|
|
|
|
|
||
Benefits and expenses: |
|
|
|
|
|
|
||
Benefits and claims |
|
|
171,293 |
|
|
|
183,425 |
|
Amortization of deferred policy acquisition costs |
|
|
90,925 |
|
|
|
62,214 |
|
Sales commissions |
|
|
105,915 |
|
|
|
129,268 |
|
Insurance expenses |
|
|
57,552 |
|
|
|
51,901 |
|
Insurance commissions |
|
|
7,666 |
|
|
|
8,412 |
|
Contract acquisition costs |
|
|
13,446 |
|
|
|
23,524 |
|
Interest expense |
|
|
6,802 |
|
|
|
7,529 |
|
|
|
|
60,000 |
|
|
|
- |
|
Other operating expenses |
|
|
73,791 |
|
|
|
79,864 |
|
Total benefits and expenses |
|
|
587,390 |
|
|
|
546,137 |
|
Income before income taxes |
|
|
85,899 |
|
|
|
147,102 |
|
Income taxes |
|
|
34,092 |
|
|
|
35,663 |
|
Net income |
|
$ |
51,807 |
|
|
$ |
111,439 |
|
Net income attributable to noncontrolling interests |
|
|
- |
|
|
|
(1,017 |
) |
Net income attributable to |
|
$ |
51,807 |
|
|
$ |
112,456 |
|
|
|
|
|
|
|
|
||
Earnings per share attributable to common stockholders: |
|
|
|
|
|
|
||
Basic earnings per share |
|
$ |
1.38 |
|
|
$ |
2.83 |
|
Diluted earnings per share |
|
$ |
1.37 |
|
|
$ |
2.82 |
|
|
|
|
|
|
|
|
||
Weighted-average shares used in computing earnings per share: |
|
|
|
|
|
|
||
Basic |
|
|
37,438 |
|
|
|
39,561 |
|
Diluted |
|
|
37,541 |
|
|
|
39,679 |
|
|
|
|||||||||||
Consolidated Adjusted Operating Results Reconciliation |
|
|||||||||||
(Unaudited – in thousands, except per share amounts) |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
Three months ended |
|
|
|
|
||||||
|
|
2022 |
|
|
2021 |
|
|
% Change |
|
|||
Total revenues |
|
$ |
673,289 |
|
|
$ |
693,239 |
|
|
|
(3 |
)% |
Less: Investment gains (losses) |
|
|
(2,699 |
) |
|
|
1,410 |
|
|
|
|
|
Less: |
|
|
(68 |
) |
|
|
(640 |
) |
|
|
|
|
Adjusted operating revenues |
|
$ |
676,056 |
|
|
$ |
692,469 |
|
|
|
(2 |
)% |
|
|
|
|
|
|
|
|
|
|
|||
Income before income taxes |
|
$ |
85,899 |
|
|
$ |
147,102 |
|
|
|
(42 |
)% |
Less: Investment gains (losses) |
|
|
(2,699 |
) |
|
|
1,410 |
|
|
|
|
|
Less: |
|
|
(68 |
) |
|
|
(640 |
) |
|
|
|
|
Less: e-TeleQuote transaction-related expenses |
|
|
- |
|
|
|
(10,027 |
) |
|
|
|
|
Less: Equity comp for awards exchanged during acquisition |
|
|
- |
|
|
|
1,004 |
|
|
|
|
|
Less: Noncontrolling interest |
|
|
- |
|
|
|
(1,465 |
) |
|
|
|
|
Less: |
|
|
(60,000 |
) |
|
|
- |
|
|
|
|
|
Adjusted operating income before income taxes |
|
$ |
148,666 |
|
|
$ |
156,820 |
|
|
|
(5 |
)% |
|
|
|
|
|
|
|
|
|
|
|||
Net income |
|
$ |
51,807 |
|
|
$ |
111,439 |
|
|
|
(54 |
)% |
Less: Investment gains (losses) |
|
|
(2,699 |
) |
|
|
1,410 |
|
|
|
|
|
Less: |
|
|
(68 |
) |
|
|
(640 |
) |
|
|
|
|
Less: e-TeleQuote transaction-related expenses |
|
|
- |
|
|
|
(10,027 |
) |
|
|
|
|
Less: Equity comp for awards exchanged during acquisition |
|
|
- |
|
|
|
1,004 |
|
|
|
|
|
Less: Noncontrolling interest |
|
|
- |
|
|
|
(1,465 |
) |
|
|
|
|
Less: |
|
|
(60,000 |
) |
|
|
- |
|
|
|
|
|
Less: Tax impact of preceding items |
|
|
647 |
|
|
|
2,449 |
|
|
|
|
|
Adjusted net operating income |
|
$ |
113,927 |
|
|
$ |
118,708 |
|
|
|
(4 |
)% |
|
|
|
|
|
|
|
|
|
|
|||
Diluted earnings per share (1) |
|
$ |
1.37 |
|
|
$ |
2.82 |
|
|
|
(51 |
)% |
Less: Net after-tax impact of operating adjustments |
|
|
(1.65 |
) |
|
|
(0.16 |
) |
|
|
|
|
Diluted adjusted operating earnings per share (1) |
|
$ |
3.02 |
|
|
$ |
2.98 |
|
|
|
1 |
% |
___________________ |
|
(1) |
Percentage change in earnings per share is calculated prior to rounding per share amounts. |
TERM LIFE INSURANCE SEGMENT |
|
|||||||||||
Adjusted Premiums Reconciliation |
|
|||||||||||
(Unaudited – in thousands) |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
Three months ended |
|
|
|
|
||||||
|
|
2022 |
|
|
2021 |
|
|
% Change |
|
|||
Direct premiums |
|
$ |
804,586 |
|
|
$ |
779,490 |
|
|
|
3 |
% |
Less: Premiums ceded to IPO coinsurers |
|
|
226,869 |
|
|
|
241,439 |
|
|
|
|
|
Adjusted direct premiums |
|
|
577,717 |
|
|
|
538,051 |
|
|
|
7 |
% |
|
|
|
|
|
|
|
|
|
|
|||
Ceded premiums |
|
|
(403,416 |
) |
|
|
(399,835 |
) |
|
|
|
|
Less: Premiums ceded to IPO coinsurers |
|
|
(226,869 |
) |
|
|
(241,439 |
) |
|
|
|
|
Other ceded premiums |
|
|
(176,548 |
) |
|
|
(158,396 |
) |
|
|
|
|
Net premiums |
|
$ |
401,169 |
|
|
$ |
379,655 |
|
|
|
6 |
% |
SENIOR HEALTH SEGMENT |
|
|||||||||||
Adjusted Operating Results Reconciliation |
|
|||||||||||
(Unaudited – in thousands) |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
Three months ended |
|
|
|
|
||||||
|
|
2022 |
|
|
2021 |
|
|
% Change |
|
|||
Loss before income taxes |
|
$ |
(63,723 |
) |
|
$ |
(8,490 |
) |
|
|
651 |
% |
Less: e-TeleQuote transaction-related costs |
|
|
- |
|
|
|
(417 |
) |
|
|
|
|
Less: Noncontrolling interest |
|
|
- |
|
|
|
(1,465 |
) |
|
|
|
|
Less: |
|
|
(60,000 |
) |
|
|
- |
|
|
|
|
|
Adjusted operating loss before taxes |
|
$ |
(3,723 |
) |
|
$ |
(6,608 |
) |
|
|
(44 |
)% |
|
|
|
|
|
|
|
|
|
|
CORPORATE AND OTHER DISTRIBUTED PRODUCTS SEGMENT |
|
|||||||||||
Adjusted Operating Results Reconciliation |
|
|||||||||||
(Unaudited – in thousands) |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
Three months ended |
|
|
|
|
||||||
|
|
2022 |
|
|
2021 |
|
|
% Change |
|
|||
Total revenues |
|
$ |
26,578 |
|
|
$ |
35,515 |
|
|
|
(25 |
)% |
Less: Investment gains (losses) |
|
|
(2,699 |
) |
|
|
1,410 |
|
|
|
|
|
Less: |
|
|
(68 |
) |
|
|
(640 |
) |
|
|
|
|
Adjusted operating revenues |
|
$ |
29,345 |
|
|
$ |
34,745 |
|
|
|
(16 |
)% |
|
|
|
|
|
|
|
|
|
|
|||
Loss before income taxes |
|
$ |
(20,519 |
) |
|
$ |
(21,365 |
) |
|
|
(4 |
)% |
Less: Investment gains (losses) |
|
|
(2,699 |
) |
|
|
1,410 |
|
|
|
|
|
Less: |
|
|
(68 |
) |
|
|
(640 |
) |
|
|
|
|
Less: e-TeleQuote transaction-related expenses |
|
|
- |
|
|
|
(9,610 |
) |
|
|
|
|
Less: Equity comp for awards exchanged during acquisition |
|
|
- |
|
|
|
1,004 |
|
|
|
|
|
Adjusted operating loss before income taxes |
|
$ |
(17,752 |
) |
|
$ |
(13,529 |
) |
|
|
31 |
% |
|
|
|||||||||||
Adjusted Stockholders' Equity Reconciliation |
|
|||||||||||
(Unaudited – in thousands) |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
2022 |
|
|
2021 |
|
|
% Change |
|
|||
Stockholders' equity (1) |
|
$ |
1,619,972 |
|
|
$ |
2,082,512 |
|
|
|
(22 |
)% |
Less: Unrealized net investment gains (losses) recorded in stockholders' equity, net of income tax |
|
|
(252,913 |
) |
|
|
63,777 |
|
|
|
|
|
Adjusted stockholders' equity (1) |
|
$ |
1,872,885 |
|
|
$ |
2,018,735 |
|
|
|
(7 |
)% |
___________________ |
|
(1) |
Reflects the Company’s permanent stockholders’ equity and does not include temporary stockholders’ equity. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221108005908/en/
Investor Contact:
470-564-6663
Email: Nicole.Russell@primerica.com
Media Contact:
404-229-8302
Email: Susan.Chana@Primerica.com
Source:
FAQ
What were Primerica's Q3 2022 earnings per share (EPS)?
How much did Primerica's revenues decline in Q3 2022?
What was the impact of the goodwill impairment on Primerica's Q3 results?
Did Primerica declare a dividend in Q3 2022?